| Literature DB >> 35736092 |
Mousa A Alghuthaymi1, Jeyapragash Danaraj2, Fawziah M Albarakaty3, Rajiv Periakaruppan4, Manigandan Vajravelu5, Saravanakumar Ayyappan6, Kumaralingam Selvaraj2, Kamel A Abd-Elsalam7.
Abstract
Elicitors are the agents that stimulate the defense responses of plants, and accumulate specialized metabolites in plant tissue culture. This study investigated the elicitor-feeding response of H. pinifolia suspension cell cultures (SCC) for metabolomics analysis and screening of specialized compounds against Candida albicans. Methyl jasmonate (MeJA) was used as an elicitor, and treatment of SCC at a concentration of 20 µM MeJA resulted in the maximum rosmarinic acid (RA) accumulation (117 mg/g dry weight), with transcript levels of RA biosynthetic genes HpPAL, HpC4H, and Hp4CL being 4.2, 2.5, and 3.7-fold higher, respectively, than the controls. GC-MS-based metabolomics analysis revealed a total of 47 metabolites, including 30 organic acids, six amino acids, six flavonoids, two sugars, two plant growth regulators, and one vitamin, which were significantly different between control and MeJA-treated cells. Furthermore, five phenolic acids were discovered at higher concentrations, including p-anisic acid, p-coumaric acid, caffeic acid, vanillic acid, and rosmarinic acid, and were purified and structurally elucidated for alternative antifungal screening against C. albicans and the evaluation of ADMET properties. The results from antifungal screening revealed that RA at MIC of 31.25 mg/L exhibited the lowest growth percentage of C. albicans (1.99%), with higher inhibition of isocitrate lyase 1 (ICL 1) enzyme (93.1%), followed by p-anisic acid (86.2%) and caffeic acid (85.1%), respectively. The drug likeliness and ADMET properties of RA exhibited promising results, with a bioactivity score of 0.57, 0.15, and 0.24 for nuclear receptor ligand, protease inhibitor, and enzyme inhibitor, respectively. Therefore, MeJA appears to have a significant effect on enhanced RA accumulation in H. pinifoia cells with phenylpropanoid transcript expression, and acts as an ICL1 inhibitor of C. albicans.Entities:
Keywords: Cymodoceaceae; Halodule pinifolia; gene expression; metabolomics; rosmarinic acid
Year: 2022 PMID: 35736092 PMCID: PMC9224785 DOI: 10.3390/jof8060609
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Figure 1Callus induction and establishment of cellular suspension of H. Pinifolia. (A)—Explant; (B)—Callus induced from Explant; (C)—Callus subculture on 3rd day; (D)—Callus subculture on 21st day; (E)—Cell suspension culture as larger clump; (F)—Suspension cultured cells at granular stage.
Figure 2PLS-DA results of score (A) and loading plots (B) of principal component 1 and 2 for polar metabolites data obtained from MeJA-treated cells and control cells of H. Pinifolia.
Figure 3HPLC chromatogram for purity check of individual compounds isolated from the extracts of H. pinifolia. (A). p-Anisic acid; (B). Caffeic acid; (C). p-Coumaric acid; (D). Vanillic acid; (E). Rosmarinic acid.
Figure 4Alternative screening approach for C. albicans growth in YNB broth supplemented with glucose or lactate as sole carbon source. Error bar in the chart represents standard deviation. (FLC—Fluconazole; ITC—Itaconic acid; ANI—p-Anisic acid; COU—p-Coumaric acid; CAFF—Caffeic acid; VAN—Vanillic acid; ROS—Rosmarinic acid).
Figure 5Percentage Inhibition of H. pinifolia-derived compounds in the ICL 1 enzyme inhibition assay.
MIC determination of potential ICL 1 inhibitor in C. albicans.
| Potential ICL Inhibitors/Test Compounds | Minimum Inhibitory Concentration (mg/L) |
|---|---|
| Fluconazole | 16 |
| Itaconic acid | 250 |
| 500 | |
| Caffeic acid | 1000 |
| Rosmarinic acid | 31.25 |
Lipinski’s rule-of-five drug-likeliness properties of potential ICL inhibitors.
| Compounds | Fluconazole | Itaconic Acid | Caffeic Acid | Rosmarinic Acid | |
|---|---|---|---|---|---|
|
| −0.12 | −0.343 | 1.91 | 0.941 | 1.63 |
|
| 81.664 | 74.598 | 46.53 | 77.755 | 144.52 |
|
| 22 | 9 | 11 | 13 | 26 |
|
| 306.276 | 130.099 | 152.15 | 180.16 | 360.32 |
|
| 7 | 4 | 3 | 4 | 8 |
|
| 1 | 2 | 1 | 3 | 5 |
|
| 0 | 0 | 0 | 0 | 0 |
|
| 5 | 3 | 2 | 2 | 7 |
|
| 248.97 | 111.171 | 136.59 | 154.50 | 303.54 |
Abbreviations: mi LogP—Hydrophobicity measurement: octanol:water partition coefficient; TPSA—Topological polar surface area; MW—Molecular weight; n ON—Hydrogen bond acceptor; n OHNH—number of hydrogen bond donor; n violations—number of Lipinski’s rule-of-five violations; n rotb—number of rotatable bonds; MV—Molecular volume.
ADMET properties of potential ICL 1 inhibitors in C. albicans.
| S. No | Admet | Fluconazole | Itaconic Acid | Caffeic Acid | Rosmarinic Acid | |
|---|---|---|---|---|---|---|
|
|
| |||||
| BBB | + | + | + | - | + | |
| HIA | + | + | + | + | + | |
| Caco-2 permeability | + | - | + | + | - | |
| Aqueous solubility | −1.8626 | −0.7363 | −1.8579 | −1.6939 | −3.2050 | |
| P-glycoprotein | ||||||
| Substrate | - | - | - | - | + | |
| Inhibitor | - | - | - | - | - | |
| ROCT | - | - | - | - | - | |
|
|
| |||||
| Subcellular localization | Mitochondria | Mitochondria | Mitochondria | Mitochondria | Mitochondria | |
|
|
| |||||
| CYP450 Substrate | ||||||
| CYP450 2C9 | - | - | - | - | - | |
| CYP450 2D6 | - | - | - | - | - | |
| CYP450 3A4 | - | - | - | - | - | |
| CYP450 Inhibitor | ||||||
| CYP450 1A2 | - | - | - | - | - | |
| CYP450 2C9 | + | |||||
| YP450 2D6 | - | - | - | - | - | |
| CYP450 2C19 | - | - | - | - | - | |
| CYP450 3A4 | - | - | - | - | - | |
| CYP Inhibitory Promiscuity | Low | Low | Low | Low | Low | |
|
|
| |||||
| HERG Inhibition | ||||||
| HERG 1 | Weak | Weak | Weak | Weak | Weak | |
| HERG 2 | - | - | - | - | - | |
| AMES Toxicity | - | - | - | - | - | |
| Carcinogens | - | - | - | - | - | |
| Rat Acute Toxicity (LD50, mol/kg) | 2.4136 | 2.4525 | 1.8917 | 1.4041 | 2.6983 | |
| Fish Toxicity (pLC50, mg/L) | 1.4529; high | 0.8180; high | 1.9309; high | 0.7921; high | −0.1231; high |
Abbreviations: BBB—Blood–brain barrier; HIA—Human intestinal absorption; ROCT—Renal organic cation transporter; CYP450—Cytochrome p 450; HERG—Human ether a-go-go-related genes.
Bioactivity score of test compounds as potential ICL 1 inhibitors.
| Drug Target | Fluconazole | Itaconic Acid | Caffeic Acid | Rosmarinic Acid | |
|---|---|---|---|---|---|
|
| 0.04 | −1.78 | −1.02 | −0.48 | 0.17 |
|
| 0.01 | 0.97 | −0.55 | −0.23 | −0.08 |
|
| −0.09 | −2.82 | −1.22 | −0.81 | −0.18 |
|
| −0.23 | −1.54 | −0.79 | −0.10 | 0.57 |
|
| −0.09 | −2.08 | −1.16 | −0.79 | 0.15 |
|
| 0.03 | −1.23 | −0.52 | −0.09 | 0.24 |